Financhill
Back

Immuron 10K Form

Sell
39

IMRN
Immuron

Last Price:
1.89
Seasonality Move:
9.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMRN News And Ratings

See the #1 stock for the next 7 days that we like better than IMRN

IMRN Financial Statistics

Sales & Book Value

Annual Sales: $3.21M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.49
Price / Book: 1.31

Profitability

EPS (TTM): -0.79870
Net Income (TTM): $-4.56M
Gross Margin: $2.19M
Return on Equity: -40.9%
Return on Assets: -35.51%

Immuron Earnings Forecast

Key Immuron Financial Ratios

  • The Gross Profit Margin over the past 10 years for IMRN is 68.06%.
  • The Selling, General & Administrative Expenses for IMRN have been equal to 133.62% of Gross Profit Margin.
  • The Research & Development expenses have been 109.64% of Revenue.
  • The Interest Expense is -0.11% of Operating Income.
  • The Net Earning history of IMRN is -141.49% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 4 years.

Immuron Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMRN
CUSIP: 45254U
Website: immuron.com.au

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.46
Quick Ratio: 4.83

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMRN Technical Analysis vs Fundamental Analysis

Sell
39
Immuron (IMRN) is a Sell

Is Immuron a Buy or a Sell?

  • Immuron stock is rated a Sell
    The current Immuron [IMRN] share price is $1.95. The Score for IMRN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.